                         SEQUENCE LISTING

<110>  Neuro-Bio Ltd
 
<120>  CANCER

<130>  AXH/73830PCT1

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  614
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Arg Pro Pro Gln Cys Leu Leu His Thr Pro Ser Leu Ala Ser Pro 
1               5                   10                  15      


Leu Leu Leu Leu Leu Leu Trp Leu Leu Gly Gly Gly Val Gly Ala Glu 
            20                  25                  30          


Gly Arg Glu Asp Ala Glu Leu Leu Val Thr Val Arg Gly Gly Arg Leu 
        35                  40                  45              


Arg Gly Ile Arg Leu Lys Thr Pro Gly Gly Pro Val Ser Ala Phe Leu 
    50                  55                  60                  


Gly Ile Pro Phe Ala Glu Pro Pro Met Gly Pro Arg Arg Phe Leu Pro 
65                  70                  75                  80  


Pro Glu Pro Lys Gln Pro Trp Ser Gly Val Val Asp Ala Thr Thr Phe 
                85                  90                  95      


Gln Ser Val Cys Tyr Gln Tyr Val Asp Thr Leu Tyr Pro Gly Phe Glu 
            100                 105                 110         


Gly Thr Glu Met Trp Asn Pro Asn Arg Glu Leu Ser Glu Asp Cys Leu 
        115                 120                 125             


Tyr Leu Asn Val Trp Thr Pro Tyr Pro Arg Pro Thr Ser Pro Thr Pro 
    130                 135                 140                 


Val Leu Val Trp Ile Tyr Gly Gly Gly Phe Tyr Ser Gly Ala Ser Ser 
145                 150                 155                 160 


Leu Asp Val Tyr Asp Gly Arg Phe Leu Val Gln Ala Glu Arg Thr Val 
                165                 170                 175     


Leu Val Ser Met Asn Tyr Arg Val Gly Ala Phe Gly Phe Leu Ala Leu 
            180                 185                 190         


Pro Gly Ser Arg Glu Ala Pro Gly Asn Val Gly Leu Leu Asp Gln Arg 
        195                 200                 205             


Leu Ala Leu Gln Trp Val Gln Glu Asn Val Ala Ala Phe Gly Gly Asp 
    210                 215                 220                 


Pro Thr Ser Val Thr Leu Phe Gly Glu Ser Ala Gly Ala Ala Ser Val 
225                 230                 235                 240 


Gly Met His Leu Leu Ser Pro Pro Ser Arg Gly Leu Phe His Arg Ala 
                245                 250                 255     


Val Leu Gln Ser Gly Ala Pro Asn Gly Pro Trp Ala Thr Val Gly Met 
            260                 265                 270         


Gly Glu Ala Arg Arg Arg Ala Thr Gln Leu Ala His Leu Val Gly Cys 
        275                 280                 285             


Pro Pro Gly Gly Thr Gly Gly Asn Asp Thr Glu Leu Val Ala Cys Leu 
    290                 295                 300                 


Arg Thr Arg Pro Ala Gln Val Leu Val Asn His Glu Trp His Val Leu 
305                 310                 315                 320 


Pro Gln Glu Ser Val Phe Arg Phe Ser Phe Val Pro Val Val Asp Gly 
                325                 330                 335     


Asp Phe Leu Ser Asp Thr Pro Glu Ala Leu Ile Asn Ala Gly Asp Phe 
            340                 345                 350         


His Gly Leu Gln Val Leu Val Gly Val Val Lys Asp Glu Gly Ser Tyr 
        355                 360                 365             


Phe Leu Val Tyr Gly Ala Pro Gly Phe Ser Lys Asp Asn Glu Ser Leu 
    370                 375                 380                 


Ile Ser Arg Ala Glu Phe Leu Ala Gly Val Arg Val Gly Val Pro Gln 
385                 390                 395                 400 


Val Ser Asp Leu Ala Ala Glu Ala Val Val Leu His Tyr Thr Asp Trp 
                405                 410                 415     


Leu His Pro Glu Asp Pro Ala Arg Leu Arg Glu Ala Leu Ser Asp Val 
            420                 425                 430         


Val Gly Asp His Asn Val Val Cys Pro Val Ala Gln Leu Ala Gly Arg 
        435                 440                 445             


Leu Ala Ala Gln Gly Ala Arg Val Tyr Ala Tyr Val Phe Glu His Arg 
    450                 455                 460                 


Ala Ser Thr Leu Ser Trp Pro Leu Trp Met Gly Val Pro His Gly Tyr 
465                 470                 475                 480 


Glu Ile Glu Phe Ile Phe Gly Ile Pro Leu Asp Pro Ser Arg Asn Tyr 
                485                 490                 495     


Thr Ala Glu Glu Lys Ile Phe Ala Gln Arg Leu Met Arg Tyr Trp Ala 
            500                 505                 510         


Asn Phe Ala Arg Thr Gly Asp Pro Asn Glu Pro Arg Asp Pro Lys Ala 
        515                 520                 525             


Pro Gln Trp Pro Pro Tyr Thr Ala Gly Ala Gln Gln Tyr Val Ser Leu 
    530                 535                 540                 


Asp Leu Arg Pro Leu Glu Val Arg Arg Gly Leu Arg Ala Gln Ala Cys 
545                 550                 555                 560 


Ala Phe Trp Asn Arg Phe Leu Pro Lys Leu Leu Ser Ala Thr Asp Thr 
                565                 570                 575     


Leu Asp Glu Ala Glu Arg Gln Trp Lys Ala Glu Phe His Arg Trp Ser 
            580                 585                 590         


Ser Tyr Met Val His Trp Lys Asn Gln Phe Asp His Tyr Ser Lys Gln 
        595                 600                 605             


Asp Arg Cys Ser Asp Leu 
    610                 


<210>  2
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  2

Lys Ala Glu Phe His Arg Trp Ser Ser Tyr Met Val His Trp Lys Asn 
1               5                   10                  15      


Gln Phe Asp His Tyr Ser Lys Gln Asp Arg Cys Ser Asp Leu 
            20                  25                  30  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NBP-14, a peptide derived from the C-terminus of 
       acetylcholinesterase with terminal Alanine (A) and Lysine (K) 
       residues required for cyclisation

<400>  3

Ala Glu Phe His Arg Trp Ser Ser Tyr Met Val His Trp Lys 
1               5                   10                  


<210>  4
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  4

Asn Gln Phe Asp His Tyr Ser Lys Gln Asp Arg Cys Ser Asp Leu 
1               5                   10                  15  


